社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Abc123
IP属地:未知
+关注
帖子 · 97
帖子 · 97
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Abc123
Abc123
·
2021-12-12
Wow
@股神不是神:
$谭仔国际(02217)$今天这么猛!
$谭仔国际(02217)$今天这么猛!
看
575
回复
评论
点赞
2
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-12-07
Wow
你会打新商汤科技吗?
@价值投资为王:
AI四小龙第一股桂冠终于落在了商汤科技身上。 虽然今日开启招股,但商汤身上的争议颇大。 一方面是业务类型高大上,AI技术门槛极高,公司汇集了40位教授、3500多位理工级学霸,年研发费用24.5亿,占总营收的比重高达71%! 另一方面,人工智能成为时代宠儿,根据相关机构研究,预测2025年中国人工智能软件市场规模高达1671亿元,是2020年的5.66倍,年复合增长率高达41.5%,是仅次于美国的第二大人工智能软件市场。 然而,AI技术在应用方面进展缓慢,当下AI四小龙主攻方向都集中在安防上,如商汤今年上半年来自安防业务的收入占比高达48%。 与政府做生意,颇受投资者诟病,毕竟回款缓慢,还面临一定的不确定性。 虽然有此缺点,但A股安防龙头海康威视依然是大牛股、长牛股,甚至得到著名私募机构高毅资产重仓持有。 因此,商汤此次IPO,你会不会打新?有价值的评论我会打赏50-300不等的虎币哦! $商汤-W(00020)$ $海康威视(002415)$
你会打新商汤科技吗?
看
791
回复
评论
点赞
3
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-11-06
Wow
Will Pfizer Outgun Merck With Oral COVID-19 Pill?
Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy
Will Pfizer Outgun Merck With Oral COVID-19 Pill?
看
911
回复
评论
点赞
5
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-11-05
Wowo
非常抱歉,此主贴已删除
看
987
回复
评论
点赞
5
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-11-04
Wow
A bargain you can’t ignore: Small-cap stocks are trading at their second-biggest discount in 20 years
Small-caps as a group appear set for a much better 2022 than large-cap equities Small-cap stocks as
A bargain you can’t ignore: Small-cap stocks are trading at their second-biggest discount in 20 years
看
781
回复
1
点赞
3
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-10-31
Wowo
非常抱歉,此主贴已删除
看
870
回复
评论
点赞
1
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-10-30
Wow
非常抱歉,此主贴已删除
看
599
回复
评论
点赞
6
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-10-24
Wow
WISH Stock: What Momentum Investors Wish To See
WISH stock spiked nearly 10% in the past three days. Without company-specific news to properly justi
WISH Stock: What Momentum Investors Wish To See
看
871
回复
评论
点赞
4
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-10-23
Wowo
非常抱歉,此主贴已删除
看
903
回复
评论
点赞
1
编组 21备份 2
分享
举报
Abc123
Abc123
·
2021-10-22
Woww
Portillo's stock soared more than 40% after it opened at $26.00 above $20 IPO price
Portillo's stock soared more than 40% after it opened at $26.00, or 30% above $20 IPO price.The comp
Portillo's stock soared more than 40% after it opened at $26.00 above $20 IPO price
看
997
回复
2
点赞
6
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3586857782182044","uuid":"3586857782182044","gmtCreate":1623763757523,"gmtModify":1623938506526,"name":"Abc123","pinyin":"abc123","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":396,"tweetSize":97,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.11%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":604991051,"gmtCreate":1639297855705,"gmtModify":1639297855814,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604991051","repostId":"856313840","repostType":1,"repost":{"id":856313840,"gmtCreate":1635149968806,"gmtModify":1635149968806,"author":{"id":"3496272380555209","authorId":"3496272380555209","name":"股神不是神","avatar":"https://static.tigerbbs.com/db2524dfea0770b8102dd44b4caca1d5","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3496272380555209","authorIdStr":"3496272380555209"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02217\">$谭仔国际(02217)$</a>今天这么猛!","listText":"<a href=\"https://laohu8.com/S/02217\">$谭仔国际(02217)$</a>今天这么猛!","text":"$谭仔国际(02217)$今天这么猛!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856313840","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606868400,"gmtCreate":1638858100825,"gmtModify":1638858100943,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606868400","repostId":"606884627","repostType":1,"repost":{"id":606884627,"gmtCreate":1638856752367,"gmtModify":1639122416282,"author":{"id":"21347731130544","authorId":"21347731130544","name":"价值投资为王","avatar":"https://static.tigerbbs.com/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"21347731130544","authorIdStr":"21347731130544"},"themes":[],"title":"你会打新商汤科技吗?","htmlText":"AI四小龙第一股桂冠终于落在了商汤科技身上。 虽然今日开启招股,但商汤身上的争议颇大。 一方面是业务类型高大上,AI技术门槛极高,公司汇集了40位教授、3500多位理工级学霸,年研发费用24.5亿,占总营收的比重高达71%! 另一方面,人工智能成为时代宠儿,根据相关机构研究,预测2025年中国人工智能软件市场规模高达1671亿元,是2020年的5.66倍,年复合增长率高达41.5%,是仅次于美国的第二大人工智能软件市场。 然而,AI技术在应用方面进展缓慢,当下AI四小龙主攻方向都集中在安防上,如商汤今年上半年来自安防业务的收入占比高达48%。 与政府做生意,颇受投资者诟病,毕竟回款缓慢,还面临一定的不确定性。 虽然有此缺点,但A股安防龙头海康威视依然是大牛股、长牛股,甚至得到著名私募机构高毅资产重仓持有。 因此,商汤此次IPO,你会不会打新?有价值的评论我会打赏50-300不等的虎币哦! <a target=\"_blank\" href=\"https://laohu8.com/S/00020\">$商汤-W(00020)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/002415\">$海康威视(002415)$</a>","listText":"AI四小龙第一股桂冠终于落在了商汤科技身上。 虽然今日开启招股,但商汤身上的争议颇大。 一方面是业务类型高大上,AI技术门槛极高,公司汇集了40位教授、3500多位理工级学霸,年研发费用24.5亿,占总营收的比重高达71%! 另一方面,人工智能成为时代宠儿,根据相关机构研究,预测2025年中国人工智能软件市场规模高达1671亿元,是2020年的5.66倍,年复合增长率高达41.5%,是仅次于美国的第二大人工智能软件市场。 然而,AI技术在应用方面进展缓慢,当下AI四小龙主攻方向都集中在安防上,如商汤今年上半年来自安防业务的收入占比高达48%。 与政府做生意,颇受投资者诟病,毕竟回款缓慢,还面临一定的不确定性。 虽然有此缺点,但A股安防龙头海康威视依然是大牛股、长牛股,甚至得到著名私募机构高毅资产重仓持有。 因此,商汤此次IPO,你会不会打新?有价值的评论我会打赏50-300不等的虎币哦! <a target=\"_blank\" href=\"https://laohu8.com/S/00020\">$商汤-W(00020)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/002415\">$海康威视(002415)$</a>","text":"AI四小龙第一股桂冠终于落在了商汤科技身上。 虽然今日开启招股,但商汤身上的争议颇大。 一方面是业务类型高大上,AI技术门槛极高,公司汇集了40位教授、3500多位理工级学霸,年研发费用24.5亿,占总营收的比重高达71%! 另一方面,人工智能成为时代宠儿,根据相关机构研究,预测2025年中国人工智能软件市场规模高达1671亿元,是2020年的5.66倍,年复合增长率高达41.5%,是仅次于美国的第二大人工智能软件市场。 然而,AI技术在应用方面进展缓慢,当下AI四小龙主攻方向都集中在安防上,如商汤今年上半年来自安防业务的收入占比高达48%。 与政府做生意,颇受投资者诟病,毕竟回款缓慢,还面临一定的不确定性。 虽然有此缺点,但A股安防龙头海康威视依然是大牛股、长牛股,甚至得到著名私募机构高毅资产重仓持有。 因此,商汤此次IPO,你会不会打新?有价值的评论我会打赏50-300不等的虎币哦! $商汤-W(00020)$ $海康威视(002415)$","images":[{"img":"https://static.tigerbbs.com/ce4aad4768d9f4e6a87c0b54953707d3","width":"821","height":"494"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606884627","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842660256,"gmtCreate":1636170730468,"gmtModify":1636170730588,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842660256","repostId":"1152406340","repostType":4,"repost":{"id":"1152406340","kind":"news","pubTimestamp":1636157546,"share":"https://www.laohunote.com/m/news/1152406340?lang=&edition=full","pubTime":"2021-11-06 08:12","market":"us","language":"en","title":"Will Pfizer Outgun Merck With Oral COVID-19 Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1152406340","media":"Benzinga","summary":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy ","content":"<p><b>Merck, Inc.</b> is locking horns with peer <b>Pfizer, Inc.</b> in what could be termed as the battle supremacy in the COVID-19 treatment market.</p>\n<p>The stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.</p>\n<p><b>Pfizer Dips Into COVID-19 Treatment Arena:</b>After acing the COVID-19 vaccine race along with its German partner <b>BioNTech SE</b>, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.</p>\n<p>The company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.</p>\n<p>The positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.</p>\n<p>Merck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.</p>\n<p>These two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.</p>\n<p><b>Pfizer Vs. Merck Data Comparison:</b>As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.</p>\n<p>Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.</p>\n<p>Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.</p>\n<p>Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.</p>\n<p>Through day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.</p>\n<p>Not only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.</p>\n<p>\"Between <b>Roche Holding AG's</b> recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.</p>\n<p><b>Authorization Before Year-End?</b>At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.</p>\n<p>It plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.</p>\n<p>BofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.</p>\n<p>Meanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.</p>\n<p>Its application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.</p>\n<p>The commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.</p>\n<p>Meanwhile, <b>Gilead, Inc.'s</b> antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Pfizer Outgun Merck With Oral COVID-19 Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Pfizer Outgun Merck With Oral COVID-19 Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 08:12 GMT+8 <a href=https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152406340","content_text":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.\nPfizer Dips Into COVID-19 Treatment Arena:After acing the COVID-19 vaccine race along with its German partner BioNTech SE, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.\nThe company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.\nThe positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.\nMerck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.\nThese two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.\nPfizer Vs. Merck Data Comparison:As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.\nOnly about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.\nSimilar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.\nMerck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.\nThrough day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.\nNot only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.\n\"Between Roche Holding AG's recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.\nAuthorization Before Year-End?At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.\nIt plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.\nBofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.\nMeanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.\nIts application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.\nThe commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.\nMeanwhile, Gilead, Inc.'s antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.","news_type":1},"isVote":1,"tweetType":1,"viewCount":911,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846667024,"gmtCreate":1636078991621,"gmtModify":1636080018594,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wowo","listText":"Wowo","text":"Wowo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846667024","repostId":"1193773478","repostType":4,"isVote":1,"tweetType":1,"viewCount":987,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846913722,"gmtCreate":1636039051015,"gmtModify":1636039121114,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846913722","repostId":"1135111496","repostType":4,"repost":{"id":"1135111496","kind":"news","pubTimestamp":1636038416,"share":"https://www.laohunote.com/m/news/1135111496?lang=&edition=full","pubTime":"2021-11-04 23:06","market":"us","language":"en","title":"A bargain you can’t ignore: Small-cap stocks are trading at their second-biggest discount in 20 years","url":"https://stock-news.laohu8.com/highlight/detail?id=1135111496","media":"MarketWatch","summary":"Small-caps as a group appear set for a much better 2022 than large-cap equities\nSmall-cap stocks as ","content":"<p>Small-caps as a group appear set for a much better 2022 than large-cap equities</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9d031143b3c5b87238d2a83a85aea5c6\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Small-cap stocks as a group are trading at a low valuation compared with large-caps. ISTOCKPHOTO</span></p>\n<p>Small-cap stocks, as a group, are bargain-priced relative to more popular large-caps, but you may be surprised at just how cheap they are. And wait until you see their performance from similar valuation levels.</p>\n<p>Look at this 20-year chart, which shows the weighted forward price-to-earnings ratio for the S&P Small Cap 600 Index versus the large-cap benchmark S&P 500 Index:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e074cb51b7e5c8bdf34daa928230789a\" tg-width=\"700\" tg-height=\"556\" width=\"100%\" height=\"auto\"><span>FACTSET</span></p>\n<p>William Watts reported on what appears to be a breakout for small-cap stocks after eight months of relatively flat performance. That is based on the movement of the Russell 2000 Index.</p>\n<p>In this article, we are focusing on the S&P Small Cap 600 Index, which is far more selective than the Russell 2000 because because most of its companies are profitable. Standard & Poor’s criteria for initial inclusion in the index includes positive earnings for the most recent quarter and for the sum of the most recent four quarters.</p>\n<p>Aside from the early coronavirus pandemic doldrums of March 2020, the S&P 600 Small Cap Index hasn’t traded this low, relative to the S&P 500, in 20 years.</p>\n<p>Here’s a breakdown of the relationship between current and average forward P/E ratios for the two indexes, using weighted data compiled by FactSet:</p>\n<p><img src=\"https://static.tigerbbs.com/3ed361a39689cb27f8eeb5593382a5b9\" tg-width=\"931\" tg-height=\"318\" width=\"100%\" height=\"auto\"></p>\n<p>The small-cap group typically trades much closer to the valuation of the large-caps than it does today.</p>\n<p>Now take a look at a 20-year comparison of total returns for the two indexes:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0166bbb3b8d142099bdbe6845dbeb332\" tg-width=\"1050\" tg-height=\"834\" width=\"100%\" height=\"auto\"><span>FACTSET</span></p>\n<p>In an extended bull market, driven in part by historically low interest rates, it is understandable that the best-known stocks (the large-caps) have had the most benefit. But all of the above argue for adding exposure to small-caps for the long term, as part of a diversified portfolio, especially if you have a lot of money in an S&P 500 index fund or exchange traded fund.</p>\n<p>For a shorter-term case, see this comparison of aggregate consensus 2022 estimates among analysts polled by FactSet for the two indexes:</p>\n<p><img src=\"https://static.tigerbbs.com/c6fb02da26aa5ed89a067e23fc87a718\" tg-width=\"1135\" tg-height=\"685\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n<p>Good numbers across the board — but the estimates are higher for the small-cap group.</p>\n<p>For both groups, the free-cash-flow estimates are comforting. Free cash flow is a company’s remaining cash flow after planned capital expenditures. It is money that can be used for expansion, dividend increases, stock buybacks or other corporate purposes.</p>\n<p>If you are fortunate enough to have access to an employer-sponsored retirement account, the most important piece of advice anyone can give you is to contribute at least as much as your employer’s maximum contribution. If you do that, you have an immediate 100% return on your contributions.</p>\n<p>Then you should look at the fees charged by the mutual funds available within the 401(k) or similar plan. Index funds, which typically have lower expenses than actively managed funds, may be available, and these may include a small-cap fund. Your plan may also allow you to put money into a brokerage account, within which you can select exchange traded index funds that also have low expenses.</p>\n<p>Here are a few ETFs that track the S&P Small Cap 600 Index:</p>\n<ul>\n <li>iShares Core S&P Small Cap ETF </li>\n <li>SPDR Portfolio S&P 600 Small Cap ETF </li>\n <li>Vanguard S&P Small Cap 600 ETF </li>\n</ul>\n<p>Among the S&P Small Cap 600, there are 24 stocks with 100% “buy” or equivalent ratings that are each covered by at least five analysts polled by FactSet. Here they are, sorted by the 12-month upside potential implied by the consensus price targets:</p>\n<p></p>\n<table>\n <tbody>\n <tr>\n <td><b>Company</b></td>\n <td><b> Industry</b></td>\n <td><b>Closing price – Nov. 3</b></td>\n <td><b>Consensus price target</b></td>\n <td><b>Implied 12-month upside potential</b></td>\n </tr>\n <tr>\n <td>QuinStreet Inc. </td>\n <td>Advertising/Marketing Services</td>\n <td>$13.44</td>\n <td>$26.80</td>\n <td>99%</td>\n </tr>\n <tr>\n <td>Tactile Systems Technology Inc. </td>\n <td>Medical Specialties</td>\n <td>$36.90</td>\n <td>$69.25</td>\n <td>88%</td>\n </tr>\n <tr>\n <td>LendingTree Inc. </td>\n <td>Finance/Rental/Leasing</td>\n <td>$151.37</td>\n <td>$238.75</td>\n <td>58%</td>\n </tr>\n <tr>\n <td>Talos Energy Inc. </td>\n <td>Oil & Gas Production</td>\n <td>$13.22</td>\n <td>$19.25</td>\n <td>46%</td>\n </tr>\n <tr>\n <td>Cytokinetics Inc. </td>\n <td>Biotechnology</td>\n <td>$36.67</td>\n <td>$52.50</td>\n <td>43%</td>\n </tr>\n <tr>\n <td>Ichor Holdings Ltd. </td>\n <td>Semiconductors</td>\n <td>$46.04</td>\n <td>$60.40</td>\n <td>31%</td>\n </tr>\n <tr>\n <td>Ultra Clean Holdings Inc. </td>\n <td>Semiconductors</td>\n <td>$55.35</td>\n <td>$72.58</td>\n <td>31%</td>\n </tr>\n <tr>\n <td>Ligand Pharmaceuticals Inc. </td>\n <td>Biotechnology</td>\n <td>$159.96</td>\n <td>$207.86</td>\n <td>30%</td>\n </tr>\n <tr>\n <td>Smart Global Holdings Inc. </td>\n <td>Semiconductors</td>\n <td>$56.22</td>\n <td>$72.00</td>\n <td>28%</td>\n </tr>\n <tr>\n <td>TTM Technologies Inc. </td>\n <td>Electronic Components</td>\n <td>$13.99</td>\n <td>$17.79</td>\n <td>27%</td>\n </tr>\n <tr>\n <td>Vista Outdoor Inc. </td>\n <td>Recreational Products</td>\n <td>$43.41</td>\n <td>$54.89</td>\n <td>26%</td>\n </tr>\n <tr>\n <td>Harmony Biosciences Holdings Inc. </td>\n <td>Pharmaceuticals: Major</td>\n <td>$42.93</td>\n <td>$53.80</td>\n <td>25%</td>\n </tr>\n <tr>\n <td>Civitas Resources Inc. </td>\n <td>Integrated Oil</td>\n <td>$53.89</td>\n <td>$66.17</td>\n <td>23%</td>\n </tr>\n <tr>\n <td>Griffon Corp. </td>\n <td>Building Products</td>\n <td>$27.22</td>\n <td>$33.33</td>\n <td>22%</td>\n </tr>\n <tr>\n <td>Korn Ferry </td>\n <td>Personnel Services</td>\n <td>$79.98</td>\n <td>$97.75</td>\n <td>22%</td>\n </tr>\n <tr>\n <td>NeoGenomics Inc. </td>\n <td>Medical/Nursing Services</td>\n <td>$46.53</td>\n <td>$56.45</td>\n <td>21%</td>\n </tr>\n <tr>\n <td>SPX Corp. </td>\n <td>Industrial Conglomerates</td>\n <td>$62.09</td>\n <td>$75.25</td>\n <td>21%</td>\n </tr>\n <tr>\n <td>LCI Industries </td>\n <td>Miscellaneous Manufacturing</td>\n <td>$149.50</td>\n <td>$178.00</td>\n <td>19%</td>\n </tr>\n <tr>\n <td>Green Plains Inc. </td>\n <td>Chemicals: Specialty</td>\n <td>$38.89</td>\n <td>$45.89</td>\n <td>18%</td>\n </tr>\n <tr>\n <td>Digi International Inc. </td>\n <td>Computer Peripherals</td>\n <td>$23.13</td>\n <td>$27.10</td>\n <td>17%</td>\n </tr>\n <tr>\n <td>Summit Hotel Properties Inc. </td>\n <td>Real Estate Investment Trusts</td>\n <td>$10.44</td>\n <td>$11.60</td>\n <td>11%</td>\n </tr>\n <tr>\n <td>Veritex Holdings Inc. </td>\n <td>Regional Banks</td>\n <td>$42.75</td>\n <td>$46.50</td>\n <td>9%</td>\n </tr>\n <tr>\n <td>Onto Innovation Inc. </td>\n <td>Electronic Production Equipment</td>\n <td>$84.29</td>\n <td>$90.20</td>\n <td>7%</td>\n </tr>\n <tr>\n <td>Axcelis Technologies Inc. </td>\n <td>Electronic Production Equipment</td>\n <td>$59.04</td>\n <td>$57.17</td>\n <td>-3%</td>\n </tr>\n </tbody>\n</table>\n<p></p>\n<p>Source: FactSet</p>\n<p></p>\n<p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A bargain you can’t ignore: Small-cap stocks are trading at their second-biggest discount in 20 years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA bargain you can’t ignore: Small-cap stocks are trading at their second-biggest discount in 20 years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 23:06 GMT+8 <a href=https://www.marketwatch.com/story/a-bargain-you-cant-ignore-small-cap-stocks-are-trading-at-their-second-lowest-discount-in-20-years-11636035174?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Small-caps as a group appear set for a much better 2022 than large-cap equities\nSmall-cap stocks as a group are trading at a low valuation compared with large-caps. ISTOCKPHOTO\nSmall-cap stocks, as a ...</p>\n\n<a href=\"https://www.marketwatch.com/story/a-bargain-you-cant-ignore-small-cap-stocks-are-trading-at-their-second-lowest-discount-in-20-years-11636035174?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPSM":"SPDR Portfolio S&P 600 Small Cap ETF",".DJI":"道琼斯","IJR":"标普小型股600指数ETF-iShares",".IXIC":"NASDAQ Composite","VIOO":"Vanguard S&P Small-Cap 600 ETF",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/a-bargain-you-cant-ignore-small-cap-stocks-are-trading-at-their-second-lowest-discount-in-20-years-11636035174?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135111496","content_text":"Small-caps as a group appear set for a much better 2022 than large-cap equities\nSmall-cap stocks as a group are trading at a low valuation compared with large-caps. ISTOCKPHOTO\nSmall-cap stocks, as a group, are bargain-priced relative to more popular large-caps, but you may be surprised at just how cheap they are. And wait until you see their performance from similar valuation levels.\nLook at this 20-year chart, which shows the weighted forward price-to-earnings ratio for the S&P Small Cap 600 Index versus the large-cap benchmark S&P 500 Index:\nFACTSET\nWilliam Watts reported on what appears to be a breakout for small-cap stocks after eight months of relatively flat performance. That is based on the movement of the Russell 2000 Index.\nIn this article, we are focusing on the S&P Small Cap 600 Index, which is far more selective than the Russell 2000 because because most of its companies are profitable. Standard & Poor’s criteria for initial inclusion in the index includes positive earnings for the most recent quarter and for the sum of the most recent four quarters.\nAside from the early coronavirus pandemic doldrums of March 2020, the S&P 600 Small Cap Index hasn’t traded this low, relative to the S&P 500, in 20 years.\nHere’s a breakdown of the relationship between current and average forward P/E ratios for the two indexes, using weighted data compiled by FactSet:\n\nThe small-cap group typically trades much closer to the valuation of the large-caps than it does today.\nNow take a look at a 20-year comparison of total returns for the two indexes:\nFACTSET\nIn an extended bull market, driven in part by historically low interest rates, it is understandable that the best-known stocks (the large-caps) have had the most benefit. But all of the above argue for adding exposure to small-caps for the long term, as part of a diversified portfolio, especially if you have a lot of money in an S&P 500 index fund or exchange traded fund.\nFor a shorter-term case, see this comparison of aggregate consensus 2022 estimates among analysts polled by FactSet for the two indexes:\n\n\nGood numbers across the board — but the estimates are higher for the small-cap group.\nFor both groups, the free-cash-flow estimates are comforting. Free cash flow is a company’s remaining cash flow after planned capital expenditures. It is money that can be used for expansion, dividend increases, stock buybacks or other corporate purposes.\nIf you are fortunate enough to have access to an employer-sponsored retirement account, the most important piece of advice anyone can give you is to contribute at least as much as your employer’s maximum contribution. If you do that, you have an immediate 100% return on your contributions.\nThen you should look at the fees charged by the mutual funds available within the 401(k) or similar plan. Index funds, which typically have lower expenses than actively managed funds, may be available, and these may include a small-cap fund. Your plan may also allow you to put money into a brokerage account, within which you can select exchange traded index funds that also have low expenses.\nHere are a few ETFs that track the S&P Small Cap 600 Index:\n\niShares Core S&P Small Cap ETF \nSPDR Portfolio S&P 600 Small Cap ETF \nVanguard S&P Small Cap 600 ETF \n\nAmong the S&P Small Cap 600, there are 24 stocks with 100% “buy” or equivalent ratings that are each covered by at least five analysts polled by FactSet. Here they are, sorted by the 12-month upside potential implied by the consensus price targets:\n\n\n\n\nCompany\n Industry\nClosing price – Nov. 3\nConsensus price target\nImplied 12-month upside potential\n\n\nQuinStreet Inc. \nAdvertising/Marketing Services\n$13.44\n$26.80\n99%\n\n\nTactile Systems Technology Inc. \nMedical Specialties\n$36.90\n$69.25\n88%\n\n\nLendingTree Inc. \nFinance/Rental/Leasing\n$151.37\n$238.75\n58%\n\n\nTalos Energy Inc. \nOil & Gas Production\n$13.22\n$19.25\n46%\n\n\nCytokinetics Inc. \nBiotechnology\n$36.67\n$52.50\n43%\n\n\nIchor Holdings Ltd. \nSemiconductors\n$46.04\n$60.40\n31%\n\n\nUltra Clean Holdings Inc. \nSemiconductors\n$55.35\n$72.58\n31%\n\n\nLigand Pharmaceuticals Inc. \nBiotechnology\n$159.96\n$207.86\n30%\n\n\nSmart Global Holdings Inc. \nSemiconductors\n$56.22\n$72.00\n28%\n\n\nTTM Technologies Inc. \nElectronic Components\n$13.99\n$17.79\n27%\n\n\nVista Outdoor Inc. \nRecreational Products\n$43.41\n$54.89\n26%\n\n\nHarmony Biosciences Holdings Inc. \nPharmaceuticals: Major\n$42.93\n$53.80\n25%\n\n\nCivitas Resources Inc. \nIntegrated Oil\n$53.89\n$66.17\n23%\n\n\nGriffon Corp. \nBuilding Products\n$27.22\n$33.33\n22%\n\n\nKorn Ferry \nPersonnel Services\n$79.98\n$97.75\n22%\n\n\nNeoGenomics Inc. \nMedical/Nursing Services\n$46.53\n$56.45\n21%\n\n\nSPX Corp. \nIndustrial Conglomerates\n$62.09\n$75.25\n21%\n\n\nLCI Industries \nMiscellaneous Manufacturing\n$149.50\n$178.00\n19%\n\n\nGreen Plains Inc. \nChemicals: Specialty\n$38.89\n$45.89\n18%\n\n\nDigi International Inc. \nComputer Peripherals\n$23.13\n$27.10\n17%\n\n\nSummit Hotel Properties Inc. \nReal Estate Investment Trusts\n$10.44\n$11.60\n11%\n\n\nVeritex Holdings Inc. \nRegional Banks\n$42.75\n$46.50\n9%\n\n\nOnto Innovation Inc. \nElectronic Production Equipment\n$84.29\n$90.20\n7%\n\n\nAxcelis Technologies Inc. \nElectronic Production Equipment\n$59.04\n$57.17\n-3%\n\n\n\n\nSource: FactSet","news_type":1},"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840758948,"gmtCreate":1635692779292,"gmtModify":1635730589071,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wowo","listText":"Wowo","text":"Wowo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840758948","repostId":"2179223073","repostType":4,"isVote":1,"tweetType":1,"viewCount":870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840063448,"gmtCreate":1635569240578,"gmtModify":1635569240637,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840063448","repostId":"2179424781","repostType":4,"isVote":1,"tweetType":1,"viewCount":599,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858670173,"gmtCreate":1635049368078,"gmtModify":1635049368234,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/858670173","repostId":"1111559375","repostType":4,"repost":{"id":"1111559375","kind":"news","pubTimestamp":1635038026,"share":"https://www.laohunote.com/m/news/1111559375?lang=&edition=full","pubTime":"2021-10-24 09:13","market":"us","language":"en","title":"WISH Stock: What Momentum Investors Wish To See","url":"https://stock-news.laohu8.com/highlight/detail?id=1111559375","media":"TheStreet","summary":"WISH stock spiked nearly 10% in the past three days. Without company-specific news to properly justi","content":"<p>WISH stock spiked nearly 10% in the past three days. Without company-specific news to properly justify positive momentum, the stock’s popularity may have been the catalyst.</p>\n<p>After trading poorly in the past few months, ContextLogic stock found its way higher again. On October 20 alone, shares were up 14%. Meanwhile, the ticker saw overwhelming volume of comments on Reddit, which may help to justify bullish market action.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e0424b0add4ae09c16fd60a8ab9616b\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Figure 1: Wish logo on a box.</span></p>\n<p>As we mentioned in previous articles, and while the stock remains near all-time lows, momentum investors might still not be too late for the party.</p>\n<p><b>Exposure may have done the trick</b></p>\n<p>A likely culprit behind WISH’s brief rally was the stock’s popularity online pushing demand for shares higher. The ticker received 150% more mentions and a whopping 35,000 upvotes – understanding that correlation between comments and upticks in share price does not necessarily indicate causation. See below the top trending stocks on Reddit on October 21.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/079bfbb083306bb71a80744d70297d15\" tg-width=\"1078\" tg-height=\"391\" width=\"100%\" height=\"auto\"><span>Figure 2: Trending stocks on Reddit on October 21.</span></p>\n<p>Another popularity tracker(see below) suggests that, in the last three months, WISH's popularity remained consistently high. However, share price had not necessarily been moving in lockstep with exposure on the discussion boards until recently. Still, it is not at all surprising that a jolt in stock price could soon follow.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e68ad670e6a136155d3e6e9abfbce3c\" tg-width=\"527\" tg-height=\"571\" width=\"100%\" height=\"auto\"><span>Figure 3: WISH stock sentiment on the WSB forum.</span></p>\n<p>The correlation between online popularity and WISH’s recent performance is consistent with the SEC’s recently released report on GameStop’s trading frenzy. The rallies seen earlier in 2021 have been primarily attributed to an increase in engagement by retail investors, enabled by platforms like Reddit. The same report also questioned the hypothesis that short covering had much to do with the massive increases in share price.</p>\n<p><b>Dip buying</b></p>\n<p>This week’s bullish attack may have also been motivated by Wish stock being so close to its all-time lows. Growth in the e-commerce space has been pressured by the “beginning of the end” of the pandemic and stay-at-home tailwinds. Also, several Wall Street experts have downgraded WISH following Q2 results, undermining positive sentiment.</p>\n<p>The above seems to have created a bearish wave. WISH has elevated short interest, at almost 25% of the float. Such high ratio can put short sellers in a vulnerable position: an increase in trading volume coupled with overbidding can force some to close their positions, kickstarting a snowball effect.</p>\n<p><b>Experts see upside</b></p>\n<p>Lastly, Wall Street currently assigns a consensus price target of $9.06 to Wish stock, signaling impressive 55% upside potential from the current sub-$6 levels. Despite an average neutral rating, even the more skeptical analysts still see gains ahead.</p>\n<p>Credit Suisse’s Stephen Ju reduced his price target from $24 to $19. He adjusted projections lower after ContexLogic missed Q2 revenue and adjusted EBITDA estimates due to lower customer retention and declining usage rates. However, the analyst still sees massive upside potential of nearly 200% ahead.</p>\n<p>Citigroup’s Nicholas Jones is not as bullish. He has a neutral rating on the stock but forecasts $7.50 on the horizon, for 23% upside potential. Q2 earnings were cited as the key reason for a price target reduction. Mr. Jones also attributed poor stock performance to the company’s difficulty in sustaining growth, especially due to higher-than-expected user churn and ad rates.</p>\n<p>On the bearish side, JPMorgan and Oppenheimer have a sell rating on the stock and $4 to $5 share price target.According to the former, decline in user activity due to the reopening of the economy, alongside Wish’s retention and rising ad costs, are the main concerns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WISH Stock: What Momentum Investors Wish To See</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWISH Stock: What Momentum Investors Wish To See\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 09:13 GMT+8 <a href=https://www.thestreet.com/memestocks/other-memes/wish-stock-what-momentum-investors-wish-to-see><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WISH stock spiked nearly 10% in the past three days. Without company-specific news to properly justify positive momentum, the stock’s popularity may have been the catalyst.\nAfter trading poorly in the...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/other-memes/wish-stock-what-momentum-investors-wish-to-see\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/memestocks/other-memes/wish-stock-what-momentum-investors-wish-to-see","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111559375","content_text":"WISH stock spiked nearly 10% in the past three days. Without company-specific news to properly justify positive momentum, the stock’s popularity may have been the catalyst.\nAfter trading poorly in the past few months, ContextLogic stock found its way higher again. On October 20 alone, shares were up 14%. Meanwhile, the ticker saw overwhelming volume of comments on Reddit, which may help to justify bullish market action.\nFigure 1: Wish logo on a box.\nAs we mentioned in previous articles, and while the stock remains near all-time lows, momentum investors might still not be too late for the party.\nExposure may have done the trick\nA likely culprit behind WISH’s brief rally was the stock’s popularity online pushing demand for shares higher. The ticker received 150% more mentions and a whopping 35,000 upvotes – understanding that correlation between comments and upticks in share price does not necessarily indicate causation. See below the top trending stocks on Reddit on October 21.\nFigure 2: Trending stocks on Reddit on October 21.\nAnother popularity tracker(see below) suggests that, in the last three months, WISH's popularity remained consistently high. However, share price had not necessarily been moving in lockstep with exposure on the discussion boards until recently. Still, it is not at all surprising that a jolt in stock price could soon follow.\nFigure 3: WISH stock sentiment on the WSB forum.\nThe correlation between online popularity and WISH’s recent performance is consistent with the SEC’s recently released report on GameStop’s trading frenzy. The rallies seen earlier in 2021 have been primarily attributed to an increase in engagement by retail investors, enabled by platforms like Reddit. The same report also questioned the hypothesis that short covering had much to do with the massive increases in share price.\nDip buying\nThis week’s bullish attack may have also been motivated by Wish stock being so close to its all-time lows. Growth in the e-commerce space has been pressured by the “beginning of the end” of the pandemic and stay-at-home tailwinds. Also, several Wall Street experts have downgraded WISH following Q2 results, undermining positive sentiment.\nThe above seems to have created a bearish wave. WISH has elevated short interest, at almost 25% of the float. Such high ratio can put short sellers in a vulnerable position: an increase in trading volume coupled with overbidding can force some to close their positions, kickstarting a snowball effect.\nExperts see upside\nLastly, Wall Street currently assigns a consensus price target of $9.06 to Wish stock, signaling impressive 55% upside potential from the current sub-$6 levels. Despite an average neutral rating, even the more skeptical analysts still see gains ahead.\nCredit Suisse’s Stephen Ju reduced his price target from $24 to $19. He adjusted projections lower after ContexLogic missed Q2 revenue and adjusted EBITDA estimates due to lower customer retention and declining usage rates. However, the analyst still sees massive upside potential of nearly 200% ahead.\nCitigroup’s Nicholas Jones is not as bullish. He has a neutral rating on the stock but forecasts $7.50 on the horizon, for 23% upside potential. Q2 earnings were cited as the key reason for a price target reduction. Mr. Jones also attributed poor stock performance to the company’s difficulty in sustaining growth, especially due to higher-than-expected user churn and ad rates.\nOn the bearish side, JPMorgan and Oppenheimer have a sell rating on the stock and $4 to $5 share price target.According to the former, decline in user activity due to the reopening of the economy, alongside Wish’s retention and rising ad costs, are the main concerns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":871,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851465850,"gmtCreate":1634923923786,"gmtModify":1634950089952,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Wowo","listText":"Wowo","text":"Wowo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851465850","repostId":"2177341559","repostType":4,"isVote":1,"tweetType":1,"viewCount":903,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853700218,"gmtCreate":1634833050813,"gmtModify":1634833050960,"author":{"id":"3586857782182044","authorId":"3586857782182044","name":"Abc123","avatar":"https://static.tigerbbs.com/e4822e10d0f39b1f7f2551c480b81cc8","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586857782182044","authorIdStr":"3586857782182044"},"themes":[],"htmlText":"Woww","listText":"Woww","text":"Woww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/853700218","repostId":"1152715784","repostType":4,"repost":{"id":"1152715784","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634829692,"share":"https://www.laohunote.com/m/news/1152715784?lang=&edition=full","pubTime":"2021-10-21 23:21","market":"us","language":"en","title":"Portillo's stock soared more than 40% after it opened at $26.00 above $20 IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=1152715784","media":"Tiger Newspress","summary":"Portillo's stock soared more than 40% after it opened at $26.00, or 30% above $20 IPO price.The comp","content":"<p>Portillo's stock soared more than 40% after it opened at $26.00, or 30% above $20 IPO price.<img src=\"https://static.tigerbbs.com/2687d25199804ec9c0af74b0e976cefb\" tg-width=\"769\" tg-height=\"370\" width=\"100%\" height=\"auto\">The company is known for its Chicago-style hot dogs, planned to raise $375 million with a market value of $1.3 billion. It was acquired by Berkshire Partners in 2014,which owns and operates a fast food chain with 67 restaurants in the Chicago metropolitan area. While the company saw a slight drop in footfall in the third quarter of 2021, it will open 600 chains in the U.S. in the future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Portillo's stock soared more than 40% after it opened at $26.00 above $20 IPO price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPortillo's stock soared more than 40% after it opened at $26.00 above $20 IPO price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-21 23:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Portillo's stock soared more than 40% after it opened at $26.00, or 30% above $20 IPO price.<img src=\"https://static.tigerbbs.com/2687d25199804ec9c0af74b0e976cefb\" tg-width=\"769\" tg-height=\"370\" width=\"100%\" height=\"auto\">The company is known for its Chicago-style hot dogs, planned to raise $375 million with a market value of $1.3 billion. It was acquired by Berkshire Partners in 2014,which owns and operates a fast food chain with 67 restaurants in the Chicago metropolitan area. While the company saw a slight drop in footfall in the third quarter of 2021, it will open 600 chains in the U.S. in the future.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTLO":"Portillo’s Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152715784","content_text":"Portillo's stock soared more than 40% after it opened at $26.00, or 30% above $20 IPO price.The company is known for its Chicago-style hot dogs, planned to raise $375 million with a market value of $1.3 billion. It was acquired by Berkshire Partners in 2014,which owns and operates a fast food chain with 67 restaurants in the Chicago metropolitan area. While the company saw a slight drop in footfall in the third quarter of 2021, it will open 600 chains in the U.S. in the future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":997,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}